FDA Inspection 728859 — Tawee Tanvetyanon

Tawee Tanvetyanon — FEI 3008891569

The FDA completed an inspection of Tawee Tanvetyanon on June 7, 2011 in Tampa, FL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 7, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Tampa, FL (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
755221 CFR 312.66Changes in research
756021 CFR 312.60FD-1572, protocol compliance